NRXS

The decision by Neuraxis to expand its ATM offering represents a significant shift in its capital strategy that presents both opportunity and risk. While the increased liquidity provides a buffer for R&D and strategic maneuvering, the scale of the expansion suggests a heightened urgency for cash. The market's ultimate verdict will depend on whether this capital is deployed toward transformative clinical progress or if it merely serves as a recurring mechanism to offset a high operational burn rate through ongoing dilution.